Trial Profile
Phase 2 Study of Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular Edema.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Mar 2012
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Triamcinolone (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Acronyms Tribeva-DME
- 14 Apr 2009 New trial record